Verona Pharma (VRNA)

NASDAQ: VRNA · Real-Time Price · USD

72.25

0.18 (0.25%)

At close: May 01, 2025, 3:59 PM

73.00

1.03%

Pre-market: May 02, 2025, 08:09 AM EDT

Verona Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	399.76M	271.77M	227.83M	148.38M	187.99M	30.07M	25.1M	42.49M	49.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	10.26M	57M	65.97M	n/a
Long-Term Investments	n/a	15M	15M	15M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	16.97M	n/a	15.07M	15.08M	n/a	n/a	n/a	1.00	n/a
Receivables	37.26M	10.95M	9.28M	15.58M	8.26M	n/a	7.11M	n/a	n/a
Inventory	6.25M	1.00	2.5M	4.04M	4.54M	3.51M	-0.00	n/a	n/a
Other Current Assets	2.73M	3.36M	3.39M	2.06M	1.72M	11.84M	7.11M	7.67M	4.97M
Total Current Assets	453.57M	289.71M	243M	170.06M	202.5M	53.66M	90.94M	117.68M	54.05M
Property-Plant & Equipment	3.15M	2.87M	927K	979K	1.16M	1.33M	26.65K	21.62K	17.07K
Goodwill & Intangibles	545K	545K	545K	545K	545K	4.19M	3.27M	3.26M	2.86M
Total Long-Term Assets	20.67M	18.42M	16.47M	16.52M	1.7M	5.52M	3.29M	3.28M	2.88M
Total Assets	474.24M	308.12M	259.47M	186.59M	204.21M	59.18M	94.23M	120.96M	56.93M
Account Payables	11.27M	3.49M	2.91M	10.04M	178K	1.93M	3.6M	1.21M	719K
Deferred Revenue	n/a	n/a	n/a	22.4M	10.86M	-0.00	106.00	152K	n/a
Short-Term Debt	1.12M	n/a	n/a	n/a	798K	n/a	n/a	n/a	n/a
Other Current Liabilities	3.55M	435K	1.41M	327K	1.57M	10.07M	9.36M	10.4M	12.69M
Total Current Liabilities	42.68M	8.69M	19.03M	33.42M	14.2M	12.61M	12.97M	11.62M	13.41M
Long-Term Debt	120.34M	48.37M	9.77M	4.87M	4.63M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	105.42M	n/a	n/a	n/a	n/a	159.81K	1.26M	1.18M	989.76K
Total Long-Term Liabilities	227M	50.15M	9.97M	5.16M	5.15M	2.17M	1.4M	1.39M	989.76K
Total Liabilities	269.68M	58.84M	29M	38.58M	19.35M	14.78M	14.37M	13M	14.4M
Total Debt	122.7M	51.33M	10.65M	5.81M	5.95M	1.25M	n/a	n/a	n/a
Common Stock	43.36M	42.77M	40.53M	31.86M	31.79M	6.9M	6.68M	7.1M	3.17M
Retained Earnings	-562.4M	-388.43M	-333.1M	-263.72M	-207.05M	-131.94M	-87.7M	-66.56M	-35.44M
Comprehensive Income	-4.6M	-4.6M	-4.6M	-4.6M	-4.6M	11.45M	n/a	n/a	-3.9K
Shareholders Equity	204.56M	249.28M	230.47M	148M	184.85M	44.4M	79.86M	107.95M	42.53M
Total Investments	15M	15M	15M	15M	n/a	10.26M	57M	65.97M	n/a